A recent study has uncovered a surprising trend: more new mothers in Denmark are using weight-loss drugs like Ozempic and Wegovy after giving birth. This is quite unusual, considering the natural weight loss and hormonal changes that typically occur postpartum. The numbers are striking. In 2018, fe
AI systems are often tricked by sneaky inputs called adversarial examples. These inputs are tweaked just enough to confuse AI models, but not enough for humans to notice. The tricky part is making these examples work well on different AI systems without being too obvious. A new method called Diff-A
Emmanuel Macron, the French President, shared his thoughts on Donald Trump's peace proposal for Ukraine. He acknowledged that the plan points in the right direction, but he believes it needs some tweaking. Macron emphasized that while peace is the goal, it shouldn't come at the cost of Ukraine's dig
Tottenham Hotspur is heading to Paris for a crucial match. After a tough loss to Arsenal, the team needs to bounce back. Fans are frustrated with the team's recent performances. The coach, Thomas Frank, might change things up. The team played a back five in the last game, but it didn't work. Now, t
Scientists have found a clever new way to make special molecules called α-CF3 allylamines. These molecules are super important in making medicines, pesticides, and other useful materials. The problem was that making them wasn't easy or efficient. The new method uses a special kind of chemistry call
The Miami Project to Cure Paralysis is more than just a research center; it's a beacon of hope for millions. It all started with a promise to Marc Buoniconti, who was left paralyzed after a football injury. His father, Nick Buoniconti, refused to accept that paralysis was untreatable. This determina
Pfizer has been making waves in the pharmaceutical world. It recently outmaneuvered Novo Nordisk to secure a deal for Metsera. This win has given Pfizer's stock a boost. But the company's success isn't just about one deal. Pfizer's third-quarter earnings were impressive. They beat Wall Street's exp
Texas just made a big move against Pfizer. They settled a lawsuit for $41. 5 million. This was about a medicine called Quillivant XR. It's used to treat ADHD in kids. The issue? Tests showed the drug didn't work as it should. It didn't dissolve in the body. But the company kept saying it was fine.
Pfizer's decision to offload its remaining shares in BioNTech (BNTX) has raised eyebrows. This move hints at a lack of faith in BioNTech's COVID-19 vaccine and its stock potential. BioNTech, once a profit powerhouse, is now facing significant losses. Its shares, though not cheap, reflect a company s
Eli Lilly, a big name in the drug world, just hit a huge milestone. It became the first healthcare company to reach a market value of $1 trillion. That's a lot of money! The company's stock hit this mark briefly during trading but then settled a bit lower, with each share going for around $1, 048.
